In the international SUMMIT trial, adults with heart failure preserved ejection fraction (HFpEF) and obesity taking tirzepatide for up to 3 years had a reduced combined risk of worsening heart failure ...

In two large studies of heart attack survivors, beta-blocker drugs benefited those with mildly impaired heart function Contradictory trial results seen in patients without heart dysfunction More data ...